Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
331-345 of 616
Promising results for self-expanding TAVR device in trial with mostly women
ACC Action CenterPromising results for self-expanding TAVR device in trial with mostly women
Hadley Wilson, MD
Innovations in Adherence: Long-Acting Agents for Infectious Diseases
Clinician's RoundtableInnovations in Adherence: Long-Acting Agents for Infectious Diseases
Charles Flexner, MD
Climate Change and Neurological Infections: The Effects Over Time
NeuroFrontiersClimate Change and Neurological Infections: The Effects Over Time
Monica Maria Diaz, M.D., M.S.
Preventive PCI versus optimal medical therapy only for vulnerable plaques
ACC Action CenterPreventive PCI versus optimal medical therapy only for vulnerable plaques
Marc Bonaca, MD
Managing Internal Medicine Issues in Hospitalized Neurological Patients
NeuroFrontiersManaging Internal Medicine Issues in Hospitalized Neurological Patients
Erick Tarula, MD
Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
NeuroFrontiersMaternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
Eliza C. Miller, MD
- advertisement
Uncovering a Potential Biomarker for Myasthenia Gravis
NeuroFrontiersUncovering a Potential Biomarker for Myasthenia Gravis
Self-assessment on statin eligibility without prescription using a web app
ACC Action CenterSelf-assessment on statin eligibility without prescription using a web app
Steven Nissen, MD
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
ACC Action CenterIncreasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Alexander J. Blood, MD
Promising results for APOC3 ASO in familial chylomicronemia syndrome
ACC Action CenterPromising results for APOC3 ASO in familial chylomicronemia syndrome
Erik Stroes
Recognizing and Addressing Medical Gaslighting in Healthcare
NeuroFrontiersRecognizing and Addressing Medical Gaslighting in Healthcare
Michele Longo, MD
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC Action CenterMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Daniel Gaudet, MD, PhD
- advertisement
Stopping aspirin after 1 month DAPT in ACS patients after stenting
ACC Action CenterStopping aspirin after 1 month DAPT in ACS patients after stenting
Gregg Stone, MD
Head-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
ACC Action CenterHead-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
Howard C. Herrmann, MD
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
ACC Action CenterAPOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
Brian Bergmark, MD
